oligopeptide-126 sh-oligopeptide-1은 임신 중 안전한가요?

Related ingredients

Frequently asked questions

oligopeptide-126 sh-oligopeptide-1은 임신 중 안전한가요?

No harmonised CLP reproductive classifications (ECHA Annex VI) or CIR/SCCS safety opinions identify reproductive or developmental hazard for cosmetic use of EGF/oligopeptide ingredients. Peer‑reviewed literature documents biological activity of EGF in tissues but does not provide evidence of maternal reproductive toxicity following topical cosmetic use; dermal bioavailability of large peptides is expected to be negligible (sources: ECHA Annex VI (no harmonised H360/H361), CIR/SCCS absence of adverse findings in cosmetic peptide assessments, PubMed literature on EGF topical use).

oligopeptide-126 sh-oligopeptide-1은 모유 수유 중 안전한가요?

No evidence from regulatory sources or peer‑reviewed studies that topical oligopeptide‑1 causes reproductive or lactation toxicity or transfers into breastmilk after cosmetic topical use; expected negligible systemic absorption of large peptides reduces lactational exposure (sources: PubMed, CosIng, PubChem entries for peptide cosmetic ingredients; no harmonised CLP classifications).

oligopeptide-126 sh-oligopeptide-1은 아기 피부에 안전한가요?

Hazard and mechanism: no specific developmental or reproductive hazard shown for topical oligopeptide‑1 (h=0,m=0). Exposure: increase by +1 for infants because skin barrier immaturity can increase dermal uptake compared with adults; although large peptides have low dermal penetration, measurable absorption cannot be ruled out for compromised/immature skin, so e=1 for 0–3 yr (sources: general dermal pharmacokinetic principles in PubMed, CosIng listing of peptide cosmetic use; no specific infant studies found).

VeriMom은 oligopeptide-126 sh-oligopeptide-1을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 oligopeptide-126 sh-oligopeptide-1을 100/100 (알려진 위험 없음)로 평가합니다.

임신 중 oligopeptide-126 sh-oligopeptide-1 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.